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ABSTRACT
Obey, Pamela M ., M.S., December, 1982 Microbiology
An Investigation of the Mechanism of Priming fo r a Pseudo­
secondary Antibody Response to IPS.
Director; Jon A. Rudbach
A typical secondary-type antibody response has been observed in  
mice given a single in jection  of lipopolysaccharide (IPS) from 
Escherichia co li 0113 21 d a f te r  treatment with e ith er of the macro­
phase toxins, carrageenan (CAR) or microparticulate s i l ic a  (MUS).
The development o f pseudo-secondary responsiveness has been shown 
to be dependent upon lysosomal damage induced by the toxins and to 
occur following immunization with extracts (presumably of 
lysosomal o rig in )  o f macrophages. Consequently, the theory has 
evolved that priming fo r a pseudo-secondary response was caused 
by a lysosomal component, released following lysosomal de- 
s ta b i l iz a t io n ,  which exhibited immunological cross-reactiv ity  
with IPS from JE. co li 0113. The mechanism of priming fo r  a pseudo­
secondary response was investigated further in the present report.
I t  was demonstrated that an immunogenic molecule(s), capable of 
sensitiz ing mice to LPS, was present in the serum a f te r  the 
administration of CAR or MUS. The appearance of the priming factor  
in serum was correlated with the onset o f lysosomal destab iliza tion  
and was prevented from occurring by s ta b il iz in g  lysosomal membranes 
with the use o f poly(-2-vinylpyrid ine-N-oxide) (PVPO). I t  was 
found that the same genetic restr ic tions applied to the generation 
of a pseudo-secondary as well as a true secondary response.
C3H/HeJ mice, LPS-nonresponders, were unable to mount a pseudo­
secondary response to LPS when i n i t i a l l y  injected with serum 
containing the priming fac to r . Nude mice, given the same treatment, 
also fa i le d  to respond in a pseudo-secondary fashion. This was 
interpreted to mean that the priming event was T -c e ll  dependent. 
However, i t  was evident th a t the priming fac tor could be liberated  
from the lysosomes of both C3H/HeJ and nude mice, as serum 
harvested from these mice a f te r  treatment with CAR was able to 
sensitize  known responders fo r a pseudo-secondary response. These 
data provided supportive evidence fo r the proposal that a lysosomal 
component which was an tigen ically  s im ilar to J [ .  coli 0113 was 
responsible fo r  priming mice for a pseudo-secondary anti-LPS 
antibody response.
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I .  INTRODUCTION
Historical background
Following an immunogenic stimulus, a series of c e l lu la r  events 
occurs p rio r to the expression of a specific immune response. These 
events are often divided into two categories: (1) the a ffe re n t limb,
which involves processing of antigen(Ag) by macrophages and leads to 
the activation  of lymphocytes and (2) the e ffe ren t limb, which includes 
the p ro li fe ra t io n  and d if fe re n t ia t io n  o f s p e c if ic a lly  activated  
lymphocytes in conjunction with the elaboration of various e ffe c to r  
molecules synthesized by these c e lls .  The type of immune response 
which is expressed depends upon the nature o f the Ag and may involve 
humoral or cell-mediated immunity, or both. Cell-mediated immunity 
is modulated d ire c t ly  by T ce lls  or by T ce ll products whereas humoral 
immunity is mediated prim arily  by antibody(Ab), a product o f B-cell 
activa tion .
As specific  immune responses, humoral and cell-mediated immunity 
share three charac teris tic  features: (1) s p e c if ic ity ,  (2 ) d iv e rs ity
and (3) memory. S p e c if ic ity  refers to the highly selective means by 
which the products of the immune response distinguish between d if fe re n t  
molecular species and react only with the Ag(or one very s im ila r  to  
i t )  which in i t ia te d  the response. The d iv ers ity  of a spec ific  immune 
response simply re f le c ts  the a b i l i t y  of the host to recognize several
1
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antigenic sites on a single immunogen and respond to each of them. The 
th ird  charac teris tic  of a specific immune response, memory, leads to 
the production of specific  ce ll populations which, upon a second exposure 
to the immunogen, give r is e  to an enhanced response. In terms of 
humoral immunity, a memory response is therefore defined by comparison 
to the primary response obtained. Typ ically , a primary response 
exhibits a la te n t period of 7-10 d between the introduction of Ag and 
the appearance of specific  Ab in the serum. Once Ab does appear, i t  
is predominantly o f the IgM class (with low levels o f IgG production) 
and does not pers is t fo r  long periods of time. A memory, or secondary, 
response, however, is characterized by a shortened la te n t  period, a 
higher peak t i t e r  of Ab which persists fo r long periods of time, and a 
predominance of IgG antibody. Heightened IgM responses have also been 
observed and described as secondary responses.
The mechanisms underlying the development of immunological memory 
have been the subject of intense investigation fo r  many years and 
researchers have often taken d if fe re n t  approaches to the study of the 
problem. One method has been to investigate the signals required for  
the activa tion  o f memory B ce lls  (B̂ )̂ and the subsequent production of 
a specific memory Ab response. Since the mid 1970s, many researchers 
have adopted the viewpoint that two signals are necessary to activate  
B|̂  ce lls  during a secondary response. This theory was based prim arily  
on the finding that T -ce ll  independent(TI) Ags were capable o f  inducing 
typical primary responses without the aid of T c e l ls ,  but were almost
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
universally incapable of generating secondary responses (9 , 31, 44,
56, 93, 94). T -ce ll dependent(TD) Ags, on the other hand, were found 
to be e ffec tive  in e l ic i t in g  both primary and secondary responses 
(17, 37, 46, 47, 67). I t  was suggested that TI Ags fa ile d  to 
stimulate secondary responses because they provided the immune system 
with an antigenic signal only and lacked the a b i l i t y  to supply a 
necessary second signal which TD Ags acquired through helper T ce ll  
function. Bacterial LPS proved to be the major exception to the ru le .
As a TI Ag, LPS was shown to stimulate both IgM and IgG memory 
responses (93, 94, 95, 96). I t  was postulated that the unique Lipid A 
portion of the molecule substituted fo r T ce ll  help and, therefore, was 
able to provide the second signal required fo r the activation  of 
ce lls .
Other investigators have chosen to study the phenomenon of  
immunological memory in terms of the generation, rather than the 
activation, of B̂  ̂ c e l ls .  Klaus (49, 50) proposed that B̂  ce ll pro­
duction in the mouse dependend upon the activation of complement and 
the subsequent deposition o f Ag-Ab-C3 complexes in lymphoid f o l l i c le s .
I t  was suggested that TI Ags fa i le d  to induce B̂  ̂ ce ll production 
because these Ags were only able to e l i c i t  IgM antibodies, which did not 
activate mouse complement and consequently did not loca lize  in fo l l ic le s .  
Embling, ^  (28) have reported s im ila r  results in the human system.
In a th ird  approach to the study of memory development, some re ­
searchers have attempted to define the structural requirements fo r  Ag
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
in the generation of secondary Ab responses. Recently, Chen, e t a l .
(21) made use of a synthetic, TD hapten-carrier system to demonstrate 
that a minimum of two antigenic sites recognizable by T ce lls  had to 
be present on each molecule in order to successfully induce IgG memory.
In view of the complex nature o f the mechanisms responsible fo r  
the generation of memory responses, i t  was o f in te res t to note the 
curious display of immunological memory observed by Becker and Rudbach 
in 1978 (11 ).  During the course o f an investigation designed to 
c la r i fy  the role o f macrophages in the induction of immunological 
responses in vivo , i t  was found that mice treated with the macrophage 
toxins, carrageenan (CAR) and microparticulate s i l ic a ,  M in-U -S il(MUS), 
produced a secondary-type Ab response when immunized with a single dose 
of LPS 21 d la te r .  I t  was determined that the response obtained was 
not due to contamination of the CAR or MUS preparations with LPS 
because two injections of these materials did not e l i c i t  a detectable 
Ab response.
The a b i l i t y  of toxin -treated  mice to exh ib it  a secondary-type 
response to a single in jec tion  of LPS has since been termed a pseudo­
secondary Ab response and fu rth e r  studies have revealed that the 
mechanisms by which CAR and MUS acted as macrophage toxins were essential 
for the development of such a response (76 ). Carrageenan, a high 
molecular weight, sulfated polygalactan, has been reported to exert 
i ts  cytotoxic effects on macrophages by causing osmotic rupture of  
lysosomal membranes (1 , 2, 3, 19). The proposal was made that CAR
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
was phagocytized and transported to secondary lysosomes in the same 
manner as other polysaccharides (22 ), but th a t ,  because of i ts  complex 
molecular structure, CAR was not digested into osmotically inactive  
partic les . Consequently, the affected lysosomes swelled and eventually 
ruptured. As a re s u lt ,  lysosomal digestive enzymes were released into  
the cytoplasm and ce ll death ensued. M icroparticulate s i l ic a  has also 
been shown to cause la b il iz a t io n  of lysosomal membranes with the sub­
sequent discharge of hydrolytic enzymes into  the surrounding tissue 
f lu id  (3 ) .  However, instead of exerting an osmotic e f fe c t ,  s i l ic a  was 
thought to induce permeability changes in the membrane by interacting  
with phospholipid or protein components o f the membrane. A th ird  in ­
h ib ito r  o f macrophage function, Thorotrast (co llo ida l thorium dioxide) 
(TT), has been demonstrated to in te r fe re  with macrophage a c t iv i ty  by 
inh ib iting  ce ll membrane synthesis rather than damaging lysosomes (98 ),  
thereby distinguishing i ts  mode of action from that of CAR and MUS.
When a comparison was made in mice between the Ab response obtained to 
a single dose of LPS and the macrophage toxin given 21 d e a r l ie r ,  i t  
was found that TT, unlike CAR and MUS, could not sensitize  fo r  a 
pseudo-secondary response to LPS. Therefore, i t  was postulated that  
destab iliza tion  o f the lysosomal membrane was a necessary prerequisite  
for the generation of a pseudo-secondary anti-LPS response (76 ).
With the knowledge that the development o f a pseudo-secondary 
response was dependent upon lysosomal rupture, the hypothesis was 
formed that a lysosomal component, which was immunologically cross- 
reactive with LPS, was released following d e s ta b il iza t io n  of the membrane
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
and was then able to prime mice to la te r  challenge with LPS (66, 76).
A recent investigation (6 6 ),  has provided supportive evidence fo r this  
theory. I t  was demonstrated that macrophage lysates generated by 
freeze-thaw fracture contained a d is t in c t determinant, presumably of 
lysosomal o r ig in ,  which cross-reacted immunochemically with LPS 
from Escherichia coli 0113, the p articu lar antigenic v a r ie ty  of LPS 
used in the study of the pseudo-secondary response. Furthermore, 
macrophage lysates were shown to prime mice fo r a pseudo-secondary Ab 
response to LPS. In the same study, i t  was suggested that the products 
released from ruptured macrophages were s p e c if ic a l ly  cross-reactive, 
immunochemically and immunologically, with LPS from coli 0113, 
because attempts to e l i c i t  a pseudo-secondary response in CAR-treated 
mice fa i le d  when LPS from IE . coli K235 was used to challenge the mice.
One o f the potential critic ism s of the pseudo-secondary response 
as a unique phenomenon has been that i t  was merely a representation  
of an enhanced primary response induced by the effects o f CAR and MUS. 
This concern was based, in part, on several published reports which 
indicated that many macrophage in h ib ito rs , in  p a rt ic u la r  CAR, could 
serve as adjuvants (15, 78, 87, 88). In one such study (8 8 ) ,  i t  was 
demonstrated that the adjuvant e ffe c t o f CAR was due to the diversion  
of Ag from the l iv e r  to the spleen, a major s ite  o f Ab formation, 
during dysfunction o f the reticuloendothelia l system(RES). Three 
observations made by Remington and Rudbach (7 6 ) ,  however, served to 
d if fe re n t ia te  the development o f a pseudo-secondary anti-LPS response
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
from that of a magnified primary response. The f i r s t  was that the 
functional state o f the RES was normal at the time of LPS challenge.
This indicated i t  was unlike ly  that any adjuvant a c t iv i ty  had occurred 
due to the in a b i l i t y  of macrophages to sequester Ag in the l iv e r  and 
prevent an abnormal uptake o f Ag by the spleen. The second and th ird  
observations involved the findings that the k in etic  and genetic re ­
quirements fo r  the generation of a pseudo-secondary response were the 
same as those fo r a true secondary response.
A second cr it ic ism  of the theory underlying the development of 
a pseudo-secondary anti-LPS response has been that CAR and MUS, as 
opposed to some lysosomal product, were responsible fo r  priming mice 
immunologically to LPS. This suggestion was in teresting  in view o f the 
s im ila r it ie s  that have been shown to ex is t between LPS, CAR and MUS.
A ll three have been recognized as macrophage toxins which exert th e ir  
effects by promoting lysosomal in s ta b i l i ty  (1 , 3, 19, 54, 57, 63, 82,
85, 91, 92 ). In add ition, both CAR and LPS have been demonstrated to 
act as adjuvants (45, 64, 78, 86, 87, 88, 92), to cause immune suppres­
sion (7 , 8 , 27, 43, 60, 70, 84, 89) and to function as B ce ll  mitogens 
(6 , 35, 51, 69, 72 ).  However, although CAR and LPS were also known 
to possess structura l s im ila r it ie s  (5 , 58, 64 ), the proposal that 
priming to LPS occurred through the d irec t action of the macrophage 
toxins themselves was highly un like ly  because MUS, which bore no 
immunochemical resemblance to LPS, was as e ffe c t iv e  as CAR in sensitiz ing  
mice fo r a pseudo-secondary response to LPS.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Statement of thesis and approach to the problem
Previous investigators have shown that mice treated with the 
macrophage toxins, CAR and MUS, produced a pseudo-secondary Ab response 
when challenged with a single dose of LPS from £ . coli 0113 21 d la te r  
(11). To explain th is phenomenon, the theory has been proposed that 
lysosomal rupture in macrophages, induced by CAR and MUS, lead to the 
l iberation  of a lysosomal component which was antigen ica lly  s im ila r  
to LPS from Ê. co li 0113 and, therefore, was able to prime mice fo r  a 
pseudo-secondary Ab response (66 ). The purpose of the present study 
was to examine the mechanism o f priming to LPS (and the subsequent 
development of immunological memory) which resulted from treatment 
with CAR or MUS. To do so, an attempt was made to determine i f ,  
in vivo, lysosomal d es tab iliza tio n  was followed by the release o f an 
immunogenic molecule which was responsible for priming mice to LPS.
In order to estimate the times at which lysosomal d es tab iliza tio n  
occurred following administration o f CAR, MUS and TT, mouse plasma 
was assayed for the presence of abnormally elevated levels o f three 
lysosomal marker enzymes -  acid phosphatase, ^-D-glucuronidase and 
^-D-galactosidase. Then, by measuring the degree of general tissue  
destruction caused by the macrophage toxins, i t  was possible to 
determine when an increase in lysosomal enzyme a c t iv i ty  indicated  
damage s p e c if ic a l ly  to lysosomes located within macrophages. Creatine 
phosphokinase and orn ith ine carbamyl transferase, re l ia b le  enzyme 
markers of muscle and l iv e r  damage, respectively , were used to assess 
nonspecific tissue destruction.
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Once the k inetics  and s p e c if ic ity  o f lysosomal enzyme release 
had been established, serum, harvested from toxin-treated  mice during 
periods of both lysosomal l a b i l i t y  and s ta b i l i t y ,  was tested fo r i ts  
capacity to prime recipients fo r a pseudo-secondary Ab response to LPS. 
In addition, an examination was made of the genetic requirements o f  
the donors and recipients used to investigate the generation of a 
pseudo-secondary response by serum transfer. Furthermore, poly{-2- 
vinylpyridine-N-oxide) (PVPO), a known lysosomal s ta b i l iz e r ,  was 
tested fo r i ts  e ffec t on the a b i l i t y  of serum from CAR and MUS-treated  
mice to prime recipients to LPS.
During the course o f th is  study, i t  was also necessary to address 
the question of whether endogenous LPS, present within the lysosomes 
of macrophages, was responsible fo r inducing the pseudo-secondary a n t i -  
LPS response. This was accomplished by two methods. F irs t ,  an ex­
periment was designed to demonstrate the e ffe c t  of CAR on the tissue
51d is tribu tion  of a Cr-labeled LPS preparation which had been injected  
previously and allowed to accumulate in the phagolysosomes of  
macrophages. Then, the in te s tin a l contents o f several mice were 
cultured fo r the presence of £ .  c o l i , a potential source of endogenous 
LPS.
F in a lly ,  because CAR has been shown to act as a B ce ll mitogen (51, 
72), i t  was important to determine i f  CAR caused the development o f  a 
pseudo-secondary anti-LPS response through polyclonal B ce ll ac tiva tio n .
The above study indicated that lysosomal destab iliza tion  was
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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followed by the l iberation  of a factor which was present in serum in 
an immunologically active form and was able to prime mice for a 
pseudo-secondary response to LPS. The release of th is factor was 
blocked by the lysosomal s ta b il iz in g  e f fe c t  of PVPO and, from the 
evidence presented, i t  did not appear that LPS i t s e l f  was responsible 
for inducing the pseudo-secondary Ab response obtained when mice exposed 
to CAR or MUS were subsequently challenged with LPS.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
I I .  MATERIALS AND METHODS
Animals. A ll mice, with the exception of the athymic nude mice, were 
fed standard lab chow and given water ad l ib itu m . The nude mice were 
maintained on autoclaved lab chow and water containing 10 mg 
tetracycline (Roche Laboratories, Nutley, NJ) per l i t e r .
( i )  ICR Swiss mice. Female Swiss outbred mice were purchased 
from Harlen-Sprague-Dawley (Indianapolis, IN) and used for experi­
mentation when 4-8 weeks old. As outbreds, the Swiss s tra in  has 
maintained nearly the same degree o f genetic va ria tion  as natural 
murine populations (77).
( i i )  RML mice. Both male and female Swiss-Webster derived mice 
were obtained from the Rocky Mountain Laboratory (RML) stock,
Hamilton, MT. Mice used fo r experiments were 4-10 weeks old.
( i i i )  C3H/HeJ mice. Female C3H/HeO mice were acquired from the 
Jackson Laboratory in Bar Harbor, ME and used fo r research when 5-6 
weeks old.
( iv )  Nude mice. Female Swiss outbred, nude mice were purchased 
from Harlen-Sprague-Dawley (Indianapolis, IN) and were used fo r  investi 
gation when 4-6 weeks old.
Macrophage toxins.
( i )  Carrageenan. Calcium carrageenan (CAR) (Seakem 9, Marine 
Colloids, Springfie ld , NJ) was suspended in warm (37°C) phosphate
n
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buffered saline (PBS) (0.15 M NaCl, 0.0033 M PO ,̂ pH 7.2) at a concen­
tra tio n  of 10 mg/ml. Then 5 mg of the CAR was administered to each 
mouse in trap er ito n e a lly  ( i . p . ) .  All suspensions were e ither used on 
the day of preparation or were discarded.
( i i )  M icroparticulate s i l i c a . S i l ic a  partic les  (M in-U-S il,  
Whittaker, Clark and Daniels, In c . ,  New York, NY) o f less than 5 tim in  
size were fractionated further according to the method of Becker and 
Rudback (1 1 ).  B r ie f ly ,  50 g o f s i l ic a  was suspended in 500 ml of 
d is t i l le d ,  deionized water (ddHgO) and subjected to ultrasonic  
vibration (Bronson, Danbury, CT) a t room temperature fo r 30 sec. The 
suspension was d ilu ted  with an additional 500 ml o f ddHgO and placed 
in a 1 1 graduated cylinder at room temperature. A fte r  allowing 24 h 
fo r  s e tt l in g  to occur, the th ird  fra c tio n , corresponding to the 
500-750 ml portion from the top, was removed and washed twice with 
ddHgO. The sediment from fraction  I I I  was dried in a 60®C oven for
48 h. In preparation fo r in jection  of the s i l i c a ,  or Min-U-Sil (MUS), 
the dry powder was suspended in warm (37°C) PBS at a concentration of 
20 mg/ml. Each mouse received 8 mg, intravenously ( i . v . ) .
( i i i )  Thorotrast. Thorium dioxide (TT) (Thorotrast, Testagar 
and Co., In c . ,  D e tro it ,  M I), containing 24-26% thorium dioxide by 
volume (260 mg/ml), 25% aqueous dextrin , and 0.15% methylparasept, 
was injected i . v .  in a volume of 0.19 ml without d ilu tio n .
Lysosomal s t a b i l i z e r . Poly(-2-v inylpyrid ine-N-oxide) (PVPO)
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
13
(Polysciences, In c . ,  Warrington, PA) was suspended in warm (37®C)
PBS at a concentration of 16 mg/ml, with each mouse receiving 4 mg/
0.25 ml, i . v .
Lipopolysaccharide. Lipopolysaccharide (LPS) from Escherichia coli 
0113 (Braude s tra in ) was supplied by J.A. Rudbach. I t  had been prepared 
as a phenol-water extract according to the method of Rudbach, et a l . 
(80). Stock solutions were made in PBS at a concentration o f 2 mg/ml 
and stored at -20*C. The appropriate d ilu tions were made ju s t  p rio r to 
use.
Collection of plasma fo r  enzyme studies. Mice were anesthetized with  
ether (Mallinkrodt Chem. Works, St. Louis, MO) and exsanguinated by 
a x i l la ry  inc is ion. The whole blood was placed in conical centrifuge  
tubes containing 25 ul of sodium heparin (1000 units/m l) per mouse bled. 
The samples were then centrifuged a t  900 x £  fo r 10 min in a re­
frigerated centrifuge and the recovered plasma e ith e r  assayed 
immediately or stored a t -70*C.
Collection o f sera fo r  passive hemagglutination assay. Mice were ex­
sanguinated by a x i l la r y  incision as described above. The whole blood 
was collected in conical centrifuge tubes and allowed to c lo t  a t  
room temperature for 1 h, a f te r  which the c lo t was rimmed and the 
samples placed in  a 4®C re fr ig e ra to r  overnight. The serum was removed 
from the c lo t ,  dispensed into  1.5 ml Eppendorf micro tes t tubes and 
centrifuged fo r 3 min in an Eppendorf centrifuge (model 5414,
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Brinkman Instruments, In c . ,  Westbury, NY) to sediment any remaining 
red c e lls .  Following heat inactiva tion  o f the sera (56*C fo r  30 min), 
the samples were stored in 4 ml v ia ls  a t -20*C.
Collection of sera fo r  passive tra n s fe r . Mice were exsanguinated by 
a x i l la ry  incision and the whole blood collected in conical centrifuge  
tubes. The blood was allowed to c lo t fo r  10 min at room temperature 
and then placed in a 37®C water bath fo r  30 min. The clots were rimmed 
and centrifuged a t  900 x £  fo r 10 min. The sera were recovered and 
transferred immediately to rec ip ien t mice by the i .p .  route.
Passive hemagglutination assay. Specific  anti-LPS t i t e r s  were measured 
by the passive hemagglutination assay (PHA). Sheep red blood ce lls  
(SRBC) (Colorado Serum Co., Denver, CO) were used as the ind icator  
cells  and were coated with LPS from E,  co li  0113 which had been boiled  
for 2.5 h a t a concentration of 1 mg/ml in 0.1 M PÔ  (pH 7 .4 ) .  In the 
coating process, 9.0 ml PBS was combined with 1.0 ml LPS and 0.25 ml 
of the packed, washed SRBC. The mixture was placed in a 37®C water 
bath fo r 30 min and resuspended every 10 min. Following incubation, 
the ce lls  were washed 3x in  cold PBS and resuspended in m ic ro tite r  
diluent (1% normal rabb it  serum)(NRS) to a concentration of 0.5%.
Normal SRBC were prepared in a s im ila r  manner. The packed, washed 
SRBC were resuspended in 1% NRS a t a concentration of 0.5%.
A 50 jul amount o f microti te r  d iluen t was added to each well of 
a m icro tite r p la te  followed by the addition of 50 ul of anti sera to
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the f i r s t  well of each row. Seria l two-fold d ilu tions were made 
with 0.05 ml d ilu ters  (Cooke Engineering Co., Alexandria, VA). F in a l ly ,  
50 111 of the 0.5% suspension o f SRBC or sensitized SRBC was added to 
each well and the plates incubated in  a humid chamber. The t i te r s  
were read a f te r  2 h at room temperature (20-22®C) and again a f te r  24 h 
at 4®C. T ite rs  were calculated from the equation, x = log2 (HD/2 ) ,  
where x represents the t i t e r  and HD corresponds to the reciprocal of  
the highest d ilu tio n  of antisera which produced hemagglutination.
Thus, the t i t e r  was equal to the well number of the endpoint when the 
f i r s t  well contained a 1/4 d ilu t io n  o f antiserum. Sera which fa i le d  
to agglutinate the sensitized red c e lls  were considered to have a 
t i t e r  o f 0, i . e .  a d ilu tio n  o f 1 /2 . A ll samples were tested in 
duplicate.
Preparation of ^^Cr-labeled LPS. LPS was labeled with ^^Cr (New England 
Nuclear, Boston, MA) according to the method of Braude, et (1 8 ) .
A 2 mg sample of LPS was added to 0.907 ml PBS containing 300 juCi o f  
^^Cr. The preparation was incubated a t 37*C fo r 2 d and shaken f r e ­
quently during that time. The labeled LPS was then dialyzed against
0.001 M PÔ  (pH 7 .2 ) a t  4®C u n ti l  the counts per minute (CPM)/ml 
dialysate had s ta b il ize d , ind icating  that a l l  the unbound ^^Cr had 
been removed from the labeled LPS preparation. Generally 3 or 4 
changes (1 l i t e r  each) o f PÔ  buffer were needed before the radio­
a c t iv i ty  in  the dialysate diminished to background levels.
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Lysosomal hydrolase a c t iv i t y . The a c t iv i t ie s  in mouse plasma o f three 
lysosomal hydrolases -  acid phosphatase, ^-D-glucuronidase and 4-D- 
galactosidase - were determined by the method of Glaser and Sly (36).
The assays were performed as described below.
(1) Acid phosphatase. A 200 Ail amount of 8 mM p-ni trophenyl 
phosphate (Sigma Chem. Co., St. Louis, MO) in 0.1 M c i t r a te ,  pH 4 .8 ,  
was incubated with 25 i l l  of plasma fo r 1 h at 37®C. At the end of 
the incubation period, 1.5 ml o f 320 mM glycine -200 mM carbonate 
buffer, pH 10.0, was added to stop the reaction. To ensure that the 
alkaline phosphatase present in the plasma was not activated by the 
addition o f the glycine-carbonate buffer, the samples were then boiled 
for 3 min to denature the active proteins.
( i i )  /g-D-glucuronidase. For th is  assay, 400 jul o f 10 mM p-
nitrophenyl yS-D-glucuronide (Sigma Chem. Co., St. Louis, MO) in 0.1 M
acetate buffer, pH 4 .8 ,  was mixed with 25 jul of plasma and incubated 
at 37®C fo r  3 h. Then, 600 jul o f  the glycine-carbonate bu ffe r, pH 
10.0, was used to terminate the reaction and the samples were boiled 
fo r 3 min.
( i i i )  /g-D-qalactosidase. A 25 jul sample o f plasma was added to 
4 0 0 jul of 10 mM p-nitrophenyl 4-D-galactopyranoside (Sigma Chem. Co., 
St. Louis, MO) in 0.1 M c i t ra te  b u ffe r ,  pH 3 .6 ,  and the reaction  
allowed to proceed a t 37*C fo r  3 h. Subsequently, 60 0 jul o f the 
glycine-carbonate bu ffe r , pH 10 .0 , was added to stop the reaction and 
the samples were boiled for 3 min.
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Reagent blanks were prepared with 25 ill of ddHgO instead of  
plasma.
In each case, centrifugation a t 10,000 x £  was necessary to re ­
move denatured protein from the solutions before measuring the 
absorbance of the nitrophenol products a t 420 nm. A ll measurements 
were made on a Coleman Junior I I  spectrophotometer (Model 5 /20,  
Perkin-Elmer Corp., Coleman Instrument D iv . ,  Oak Brook, IL ) .  A ll 
tests were performed in duplicate or t r ip l ic a t e .  A c t iv ity  was ex­
pressed as nmoles product formed/ length o f incubation time.
Ornithine carbamyl transferase. The level o f orn ith ine carbamyl 
transferase (OCT) a c t iv i ty  in mouse plasma was detected using a pro­
cedure ( k i t  108 purchased from Sigma Chem. Co., St. Louis, MO) based 
on the m icrodiffusion-Nesslerization method described by Reichard (75).  
The action of OCT in th is  procedure is to catalyze the reaction be­
tween c i t r u l l in e  and arsenate, forming orn ith ine and carbamyl arsenate. 
However, carbamyl arsenate is unstable and decomposes, l ib e ra tin g  
COg and NHg. The amount of NĤ  can be quantified and is proportional 
to the serum (plasma) OCT a c t iv i ty .
To in i t i a t e  the assay, e ith er 1.0 ml o f 0.1 M c i t r u l l in e -0 .5  M 
arsenate bu ffe r , pH 7 . 1 , (Test) or 1.0 ml o f 0.5 M arsenate b u ffe r ,  pH 
7 .1 , (Blank) was added to 1.0 ml plasma and incubated at 37*C fo r  24 h. 
Subsequently, 0.2 ml o f 4 N perchloric acid was added to each sample 
and the resu lting  p rec ip ita te  was sedimented by centrifugation at
10,000 X £  fo r  10 min. Next, 1.0 ml of e ith e r  the Test or Blank
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supernatant was pipetted into the outer chamber o f a Cuprak dish 
(Costar, Cambridge, MA) along with 3.0 ml o f a 0 .4  M borate buffer,  
pH 13.0. To the center chamber was added 1.5 ml of 0.01 N HCl. The 
dishes were incubated a t 3 7 ° C  fo r  2.5 h, during which time the ammonia 
liberated was trapped by the HCl.
To quantify the amount o f ammonia formed, 1.0 ml o f the HCl 
solution from the Test or Blank center chamber was added to a test  
tube containing a 3.5 ml ddHgO and 0.5 ml Sigma Ammonium Color Reagent 
(Stock no. 14 -2 ). A fte r  10 min at room temperature, the absorbancles 
of the Blank and Test samples, with ddHgO as a reference, were read at 
420 nm on a Coleman Junior spectrophotometer. OCT a c t iv i ty  was c a l­
culated from an established ca lib ra tion  curve and the plasma a c t iv i ty  
determined by subtracting the a c t iv i ty  in the Blank from that o f the 
Test. A ll assays were performed in duplicate.
Creatine phosphokinase. Creatine phosphokinase (CPK), an indicator o f  
mycardial damage, was assayed fo r in mouse plasma by a modification  
( k i t  520 purchased from Sigma Chm. Co., St. Louis, MO) o f the procedure 
described by Hughes (4 2 ) .  In the te s t ,  phosphocreatine acts as a sub­
strate fo r  CPK and, in the presence of AGP, is converted to creatine .  
The amount o f creatine formed is porportional to CPK a c t iv i ty .
B r ie f ly ,  0.5 ml o f the phosphocreatine solution provided was in ­
cubated a t  37°C fo r  15 min with e ith er  0.1 ml o f  a 10-fold  d i lu t io n  of  
plasma (Test) or 0.1 ml o f ddHgO (Blank). To each tube, 0.2 ml ADP- 
glutathione was added and the reaction was allowed to proceed at 37®C
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for exactly 30 min. Then, 0.2 ml of p-hydroxymercuribenzoate was 
used to stop the reaction. In order to induce color development, 1.0  
ml «-naphthol, 1.0 ml o f a diacetyl solution, and 1.0 ml o f ddHgO 
were added to the reaction mixture and the tubes were placed in a 37®C 
water bath for 15 to 20 min. The absorbancles at 520 nm o f Test 
samples were recorded with the Blank as a reference. CPK a c t iv i ty  
was then read d ire c t ly  from a ca lib ra tion  curve previously prepared.
Plaque-forming ce ll  assay. The number of d irect plaque-forming ce lls  
(PFC) specific  fo r  SRBC, ra t  RBC (RRBC) and LPS from E.  co li 0113 and 
0111 were quantified  by a hemolytic plaque assay. SRBC were used as 
the indicator c e l ls  fo r  the LPS antigens and were coated with e ith e r  
LPS from Ê . co ll 0113 or 0111 as described in the PHA procedure. Spleens 
were removed from mice and single ce ll suspensions prepared by 
pressing the spleens through a 40 mesh stainless s te l l  w ire grid into  
cold 2x Eagle's Medium (Grand Island Biological Co., Grand Is land, NY) 
buffered with 0.1 M Tris-HC l. The suspensions were allowed to s e t t le  
in an ice bath in  15 ml conical centrifuge tubes for 5 min in order to 
remove ce ll  debris. A fte r  transferring  the supernatant f lu id  to fresh 
centrifuge tubes, the c e lls  were washed once with 2x Eagle's and then 
suspended in 10 ml o f  0.83% NH^Cl and kept a t room temperature fo r  5 
to 10 min to lyse the erythrocytes. The cells  were washed once with  
2x Eagle's and then suspended in 2.0 ml of Ix Eagle's per spleen. The 
dilutions appropriate fo r p lating were made in Ix  Eagle's.
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Trypan blue (0.04%) exclusion was used to indicate ce ll v i a b i l i t y  
and the numbers o f l iv e  spleen cells/m l media were calculated from 
counts obtained with a hemocytometer.
Individual tubes containing 2.0 ml of 1.0% agar (Bacto Agar,
Difco Laboratories In c . ,  D e tro it ,  MI) in Ix  Eagle's were prepared and 
kept melted in a 45*C water bath. Just p rio r  to p la ting , 0 .2  ml of  
1% DEAE-dextran (Pharmacia Fine Chemicals, Upsala, Sweden) was added 
to the agar, followed by 0.2 ml o f the appropriate 30% red ce ll  sus­
pension and 0.2 ml o f the spleen ce ll  suspension. The tubes were 
quickly inverted 3x and the contents poured into 60 x 15 mm p la s tic  
petri p lates. A fte r  the agar had s o l id i f ie d ,  the plates were placed 
in  a humid chamber and incubated a t 37*C fo r 2 h. Following incubation,
3.0 ml o f guinea pig complement (Colorado Serum Co., Denver, CO), 
diluted 1:30 in a standard complement d iluent (PBS with 9 x 10"^ M 
CaClg and 5 x 10”  ̂ M MgClgHgO), was added to each p la te . The plates  
were then incubated a t  37*C fo r  an additional 45 min, a f te r  which 
the number o f plaques/plate were counted. A ll tests were performed 
in duplicate and the average number of PFC was calculated. The PFC 
response was then expressed in terms of the number o f PFC/spleen.
Co-agglutination te s t . Bacterial colonies, isolated from the in te s t in a l  
contents of both male and female RML mice, which were composed of  
lactose-fermenting. Gram negative rods were analyzed fo r the a b i l i t y  
to cross-react with JE. co li 0113 by the co-agglutination te s t  (3 0 ) .
This tes t makes use o f  the fac t that the Cowen stra in  of
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Staphylococcus aureus is rich  in Protein A, which binds the portion  
of IgG molecules. Consequently, the antibody-coated aureus 
becomes a reagent which agglutinates in the presence of homologous 
antigen.
A commercial aureus preparation {Pansorbin, Calbiochem-Behring 
Corp., La J o l la ,  CA) was coated with antiserum containing IgG a n t i ­
bodies specific  fo r LPS 0113. A 10 ul sample of anti serum was added 
to 100 jul of the _S. aureus suspension. The sensitized suspension was 
washed once with PBS in order to remove any unbound antibodies and 
then was d ilu ted to 1 ml with PBS and stored a t 4®C.
The tes t procedure was carried out by adding one drop of a heavy 
bacterial suspension to an equal volume of sensitized aureus.
The samples were mixed thoroughly and read a t the end o f 2 min against 
a dark background. Agglutination was graded from 0 to 4 on the basis 
of the degree of clumping observed and was considered positive i f  the 
test wells appeared granular (+2) or exhibited a s l ig h t  to heavy 
f loccular appearance (+3 to +4) and both negative controls and 
staphylococcal reagent sensitized with other, unrelated, antibodies 
remained uniformly smooth and nongranular (0 ) .  A +1 reaction corresponded 
to a barely perceptible granular appearance. I f  nonspecific agglu­
tina tion  was observed, the tes t was considered positive only i f  there  
was a d is t in c t  d ifference (+4 versus +1 or +2) in  agglutination between 
the tes t well and negative controls. Two reagents were used as 
negative controls. They included a nonsensitized Ŝ. aureus
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preparation and a staphylococcal suspension sensitized with NRS, 
which was devoid of antibodies to the antigens tested. In addition, 
samples of the aureus suspension were sensitized with antisera  
directed against JE. coli 0111 in order to explore the degree of cross­
re a c t iv i ty ,  i f  any, observed. Anti-ovalbumin sera provided the source 
of unrelated anti sera and a known culture o f E,  coli 0113 was used 
to demonstrate positive agglutination.
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I I I .  RESULTS
S p e c if ic ity  o f lysosomal rupture induced by various toxins for 
macrophages. According to the mechanism proposed fo r the generation 
of a pseudo-secondary response to LPS following treatment with CAR 
or MUS, the lysosomes of macrophages which had ingested the toxins 
were ruptured, leading to a discharge of lysosomal contents into the 
cell cytoplasm and, thus, into the surrounding tissue f lu id  (7 6 ).  I t  
was postulated th at among the components released was a fac tor which 
was cross-reactive with LPS and therefore was able to prime mice to 
la te r  challenge with LPS. The unsuccessful attempt to induce a pseudo­
secondary response with TT was suggested to be the resu lt o f the 
in a b i l i ty  o f TT to destab ilize  the lysosomal membranes w ith in  phago- 
cytizing macrophages and cause the release o f the priming factor.
In an e f fo r t  to determine when the priming factor was availab le  
fo r  in teraction  with the host Immune system, a study was undertaken to 
monitor the periods of lysosomal d es tab iliza tion  following treatment 
with CAR and MUS. Abnormally elevated levels o f the acid hydrolases- 
f-D-galactos1dase (2 -G a l) ,  4^D-glucuronidase C2-GlcU), and acid 
phosphatase (AcPh) -  In  mouse plasma served to Indicate when lysosomal 
rupture was taking place. For the sake of comparison, an assessment 
was also made of the degree to which lysosomal enzyme a c t iv i ty  
increased In  mouse plasma a f te r  administration of TT.
23
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The macrophage toxins described above have been shown to induce 
a varie ty  o f pathological e ffects (2 , 27, 55). In addition, the 
degradation of various tissue components by lysosomal enzymes re­
leased from damaged macrophages has been suggested to occur as a 
secondary consequence of the phagocytosis of toxin (4 , 25, 26). As a 
re s u lt ,  i t  was also necessary to assay for general tissue destruction  
in order to determine i f  the hydrolase a c t iv i t ie s  detected were repre­
sentative o f  damage specific  fo r macrophages or i f  they were the resu lt  
of damage to other tissues. Plasma levels of creatine phospho­
kinase (CPK), sp ec ific  fo r  myocardial and skeletal muscle in ju ry ,  
and orn ith ine carbamyl transferase(OCT), a sensitive measure o f l iv e r  
damage, were used to assess overall tissue destruction. Groups o f  
three mice each were treated with the macrophage toxins or with PBS 
and were exsanguinated at various times a f te r  treatment. The blood 
collected was pooled and the plasma recovered fo r  enzyme analyses.
Fig. 1 i l lu s t r a te s  the kinetics o f lysosomal enzyme release a f te r  
administration o f CAR (Lines A-C). The acid hydrolases showed two 
peaks in a c t iv i ty ;  the f i r s t  Occurred fo r a l l  three hydrolases at  
6-8 h post-treatment. Failure to detect an increase in  a c t iv i ty  fo r  
OCT or CPK (Lines D and E, respectively) at th is time suggested that  
the elevated hydrolase a c t iv i ty  was due to the rupture o f lysosomes 
s p e c if ic a l ly  w ith in  macrophages. The second peak in  hydrolase a c t iv i ty  
occurred from 12(AcPh, Line A) to 16 h (#-Gal and f-G lcU; Lines 8 and C, 
respectively) and was accompanied by a dramatic increase in  OCT plasma
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levels . (The CPK a c t iv i ty  remained close to normal a t a l l  the times 
examined.) This implied that in ju ry  to hepatocytes may have resulted  
in the dysfunction or rupture of lysosomes within these ce lls  and, 
therefore, that the lysosomal marker enzymes were not re l ia b le  in ­
dicators of damage to macrophages a f te r  8 h of exposure to CAR.
Similar results fo r  MUS-treated mice are shown in Fig. 2. The a c t iv i t ie s  
of the acid hydrolases peaked for the f i r s t  time from about 4-6 h a f te r  
administration o f the toxin . A corresponding rise  in OCT or CPK 
plasma levels was not seen at th is  time, but by 16 h, as the lysosomal 
enzyme levels  peaked again, there was a concomitant increase in  both 
OCT and CPK a c t iv i ty .  Fig. 3 i l lu s tra te s  the time course o f lysosomal 
enzyme a c t iv i ty  following in jection  of TT. Again each o f the acid 
hydrolases showed a biphasic pattern of a c t iv i ty ,  although the peaks 
fo r each occurred at d if fe re n t  time intervals  (AcPh at 6 and 24 h.
Line A; ^-Gal a t 4 and 24 h. Line B; A-GlcU at 4 and 12 h. Line C). 
Unfortunately, a lim ited  supply o f TT prevented evaluation o f  CPK and 
OCT a c t iv i ty .
A comparison o f the kinetics o f lysosomal enzyme release following  
the administration o f  CAR and MUS revealed that lysosomal d e s ta b i l i ­
zation took place e a r l ie r  in MUS-treated mice than i t  did in mice 
given CAR. This observation confirmed a previous report which demon­
strated that CAR exerted i ts  cytotoxic effects on macrophages more 
slowly than MUS (3 ) .  I t  was also noted that mice exposed to MUS ex­
h ibited higher levels  o f hydrolase a c t iv i ty  in th e ir  plasma than did
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CAR-treated mice. This difference in the extent of lysosomal enzyme 
release was d i f f i c u l t  to in te rp re t .  Some investigators have suggested 
that as the phagocytic load increased, the degree to which lysosomal 
enzymes accumulated in the surrounding tissue f lu id  also increased (24). 
Therefore, i t  was possible that MUS exceeded CAR in the capacity to 
induce the release of lysosomal enzymes because the dose of MUS that  
was given represented a greater phagocytic load to macrophages than 
did the dose of CAR. However, the route by which each o f these toxins 
was administered may also have played a s ig n if ic a n t ro le in the extent 
to which lysosomal hydrolases accumulated in  plasma. MUS was injected
i . v . ,  whereas CAR was administered by the i .p .  route. Consequently, 
i t  was possible that treatment with MUS lead to a higher increase in 
hydrolase a c t iv i ty  simply because i t  was more widely distributed  
throughout the tissues and was phagocytized by a larger number of  
macrophages which, in turn , released large amounts of hydrolytic  
enzymes following d es tab iliza tion  of lysosomal membranes.
The levels o f hydrolase a c t iv i t ie s  seen a f te r  stimulation with  
TT, especially during the f i r s t  peaks, were lower than those detected in 
either MUS or CAR-treated mice. This was most l ik e ly  the re su lt  o f the 
d iffe re n t mechanism by which TT was thought to function as a macro­
phage toxin. CAR and MUS were thought to act on lysosomes d ire c t ly ,  
leading to rupture of these vesic les , while TT was postulated to 
in te r fe re  with ce ll  membrane synthesis and not markedly a ffe c t lysosomal 
s ta b i l i ty .
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In general, i t  appeared that treatment with the macrophage toxins 
resulted in a biphasic pattern of lysosomal enzyme release. The f i r s t  
rise in hydrolase a c t iv ity  seemed to be specific  for damage to macro­
phages. The second peak in a c t iv i ty ,  however, may have been the result 
of in ju ry  to other tissues, recycling of the macrophage toxins, or a 
combination of both. From these resu lts , i t  must be assumed that the 
plasma levels o f acid hydrolase a c t iv i ty  were accurate markers fo r the 
destab iliza tion  of lysosomal membranes w ith in  macrophages during the 
f i r s t  8 h o f exposure to the toxins, but not thereafte r.
Effects of sera from mice treated with CAR, MUS, or TT on the generation 
of a pseudo-secondary Ab response to LPS. A fte r  having established 
that lysosomes, s p e c if ic a lly  located w ithin macrophages, were damaged 
6 h post-treatment with CAR or MUS, an experiment was designed to test  
the hypothesis that priming fo r a pseudo-secondary response to LPS 
was caused by a factor which was released from lysosomes following 
d estab iliza tion  o f the membrane by macrophage toxins. I t  was postulated 
that i f  a factor which was cross-reactive with LPS was released a fte r  
lysosomal rupture, and i f  i t  was present in serum in an Immunologically 
active form, then recipients o f serum harvested from mice exposed to 
CAR and MUS should have exhibited a pseudo-secondary response upon 
challenge with LPS. Serum was transferred 6 h a f te r  treatment as well 
as at several other times in order to determine when, i f  at a l l ,  and 
fo r how long the priming factor was active in  serum. Table 1 shows the
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Figure 1. Kinetics and s p e c if ic ity  o f lysosomal enzyme release  
induced by treatment with CAR. Mice were in jec ted , i . p . ,  w ith  
5 mg CAR or an equivalent volume of PBS (normal mice). Enzyme 
analyses of plasma pooled from 3 mice were performed post­
treatment at the times indicated. For each enzyme studied, the 
level o f a c t iv i ty  present in the CAR-treated mice was expressed 
as X(enzyme a c t iv i ty  in normal mice). Each value shown 
represents the mean o f three experiments.
Symbols:
Line A: Acid phosphatase
Line B: i-D-galactosidase
Line C: #-D-glucuronidase
Line D: Ornithine carbamyl transferase
Line E: Creatine phosphokinase
t :  Indicates time of in jection o f CAR
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Figure 2. Kinetics and s p e c if ic ity  of lysosomal enzyme release  
following the administration o f MUS. Mice were in jec ted ,
i . v . ,  with 8 mg MUS or an equivalent volume of PBS (normal 
mice). Enzyme analyses of plasma pooled from three mice were 
performed post-treatment at the times indicated. For each 
enzyme studied, the level of a c t iv i ty  present in  MUS- 
treated mice was expressed as x(enzyme a c t iv i ty  in normal 











Ornithine carbamyl transferase  
Creatine phosphokinase 
Î :  Indicates time of in jec tio n  o f MUS
30











'JsHBneüsBBESiiTz 00 N  O
IV W H O N  X
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 3. Kinetics of lysosomal enzyme release induced by the 
administration o f TT. Mice were in jec ted , i . v . ,  with e ith e r  
50 mg TT or an equivalent volume of PBS (normal mice). Enzyme 
analyses of plasma pooled from three mice were performed post­
treatment at the times indicated. For each enzyme studied, the 
level of a c t iv i ty  present in TT-treated mice was expressed 
as x(enzyme a c t iv i ty  in normal mice). Each value shown 
represents the mean of three experiments. A lim ited  supply 









Indicates the time of in jec tion  o f TT
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Day 15 Day 19
Donor Recipient
Experimental
Group 1 2 3 mean
A CAR d. s. 6 h post CAR PBS 0.0 0.0 — 0.0
B CAR d. s. 6 h post CAR LPS 8.0 8.0 8.0 8.0
C CAR d. s. 12 h post CAR LPS 6.0 7.0 7.0 6.7
D CAR d. s. 16 h post CAR LPS 7.0 6.0 6.5 6.5
£ CAR d. s. 48 h post CAR LPS 7.0 8.0 8.0 7.7
F CAR d.s. 5 d post CAR LPS 6.0 6.5 6. 0 6.2
G MUS d. s. 6 h post MUS PBS 0,0 0.0 - 0.0
H MUS d.s. 6 h post MUS LPS 7.0 7.0 7.0 7.0
I MUS d.s. 12 h post MUS LPS 8.0 8.0 8.0 8.0
J MUS d.s. 16 h post MUS LPS 8.0 8.0 9.0 8.3
K MUS d.s. 48 h post MUS LPS 6.5 7.0 6.0 6.5
L MUS d.s. 5 d post MUS LPS 5.0 5.5 5.0 5.2
M TT d.s. 6 h post TT PBS 0.0 0.0 - 0.0
N TT d.s. 6 h post TT LPS 6.0 5.0 - 5.5
0 TT d.s. 5 d post TT LPS 6.0 5.0 5.0 5.3
P PBS d.s. 6 h post PBS LPS 5.0 5.0 5.0 5.0
Q - PBS PBS 0.0 0.0 - 0.0
R - PBS LPS 4.0 4.0 - 4.0
S - CAR LPS 8.0 7.0 - 7.5
T - LPS LPS 8.0 7.0 - 7.5
derived from the equation, x=logi(HD/2), where HD was the reciprocal of the highest dilution of sera 
that produced hemagglutination. Each experimental group value represents the titer of sera pooled 
from three to five mice.
b. 5 mg CAR, i.p.; 8 mg MUS, i.v.; 50 mg TT, i.v.; 0.30-0.35 ml donor serum(d.s.), i.p.
c. 10 ug LPS from £.. coli 0113, i.p.
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capacity o f sera from mice treated with CAR, MUS, or TT to prime 
recip ient mice fo r  a pseudo-secondary antibody response to LPS.
Serum taken from CAR-stimulated donors at 6 and 48 h (Groups B and E) 
was able to prime recipients for a pseudo-secondary response (as 
compared to a true secondary response in  Group T). While the 
recipients o f serum harvested 12 h, 16 h, and 5 d a f te r  exposure to 
CAR (Groups C, D, and F) did exh ib it a higher anti-LPS antibody 
response than those which received normal mouse serum (Group P), 
there was not a great enough difference between the t i t e r s  observed 
to consider the responses shown in Groups C, D, and F as pseudo­
secondary responses. (Various groups must show a t least a two tube 
difference in t i t e r  fo r them to be considered s ig n if ic a n t ly  d i f fe re n t . )  
Serum from MUS-treated donors was able to prime recipients fo r a pseudo­
secondary response when i t  was obtained 6, 12, and 16 h a f te r  adminis­
tra t io n  o f the toxin (Groups H, I ,  and J ) .  By 48 h, serum from donors 
given MUS was no longer able to prime fo r  an anti-LPS response that was 
s t a t is t ic a l ly  in  the range of a pseudo-secondary response (Group K) 
and by 5 d, serum from the same donors was in e ffe c tiv e  for sensitiz ing  
recipients to LPS (Group L). Serum obtained from donors treated with 
TT was unable to prime recipients fo r  a pseudo-secondary response at 
any of the times examined (Groups N and 0 ) .  Unfortunately, a lim ited  
supply o f TT prevented a more thorough study. Groups A, G, and M 
demonstrated th at the pseudo-secondary response observed in other groups
was not a manifestation of residual antibody induced by the i n i t i a l  in ­
jec tio n  o f serum from toxin-treated  mice.
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Comparison of serum vs. plasma in generating a pseudo-secondary 
Ab response. A series of experiments was set up to determine the 
effectiveness of plasma in generating a pseudo-secondary antibody 
response to LPS. This became necessary in view of the fac t that 
the enzyme assays used to monitor the rupture o f lysosomal membranes 
and the release of lysosomal products were performed with plasma 
while the passive transfers shown to be capable of priming mice fo r a 
pseudo-secondary response u t i l iz e d  serum. As a resu lt o f th is  variance 
in procedure, the following experiments were designed to te s t whether 
or not the plasma-serum systems were equivalent fo r the purposes of  
th is study. Donor mice were given 5 mg CAR, i . p . ,  and exsanguinated 
6 h la te r .  A pool was made of the blood collected and e ith e r  the 
plasma or serum recovered. Transfers of serum, plasma, or serum 
treated with heparin were then made to rec ip ien t mice which were 
challenged with LPS 15 d la te r .  As shown in Table 2, plasma (Group B), 
as well as serum (Group A), was able to prime mice fo r a pseudo­
secondary response to LPS. In addition, heparin (Group C) did not 
in te r fe re  with the fac tor found in serum and plasma which was 
responsible fo r  the priming event. Therefore, i t  appeared th a t the 
plasma-serum systems were equivalent.
S ta b il iz a t io n  o f the lysosomal membrane with the use of poly(2-
vin .ylpyridine-N-oxide). Previous studies (3) have shown th at poly(2-
vinylpyrid ine-N-oxide ) (PVPO) protected macrophages from lysosomal









































Day 15 Day 19
Donor Recipient
Experimental
Group 1 2 3 mean
A CAR d.s. 6 h post CAR LPS 8.0 7.0 8.0 7.7
B CAR d.p. 6 h post CAR LPS 7.0 6.5 7.0 6.8
C CAR d.s. + 50 ul heparin 
6 h post CAR
LPS 7.5 7.0 7.0 7.2
0 PBS d.s. 6 h post PBS LPS 4.0 4.0 — 4.0
E - LPS LPS 7.0 8.0 - 7.5
F - PBS LPS 4.0 4.0 - 4.0
W
derived from the equation, x=logi(HD/2), where HD was the reciprocal of the highest dilution of 
sera that produced hemagglutination. Each experimental group value represents the titer of sera 
pooled from four or five mice,
b. 5 mg CAR, i.p.; 10 ug LPS from E. coli 0113, i.p.; 0.30 - 0.35 ml of either donor serum(d.s.) or 
donor plasma{d.p.), i.p. 
c- 10 ug LPS from E. coli 0113, i.p.
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disruption and the resu ltan t cytotoxic effects o f m icroparticulate s i l ic a  
(MUS) in v i t r o . I t  was suggested that PVPO blocked the action of s i l ic a  
by s ta b il iz in g  the lysosomal membranes of affected c e lls .  Based on th is  
information, PVPO was used in an attempt to prevent lysosomal de- 
s ta b il iza t io n  in vivo by CAR and MUS. Groups of three mice each 
were injected with PVPO 1 hr prior to administration o f e ith e r  the 
macrophage toxins or PBS. The mice were exsanguinated a t  various 
times post-treatment and the plasma collected from each group was pooled 
for enzyme analyses. The enzymes under study included the three 
lysosomal markers used previously to estimate lysosomal in te g r ity  - 
AcPh, ^-Gal, and ^-GlcU. The e f fe c t  of PVPO on the a b i l i t y  o f CAR 
and MUS to des tab ilize  the lysosomal membranes of ac tive ly  phag- 
ocytizing macrophages is i l lu s tra te d  in Figs. 4 and 5, respectively.
In both cases, the marker enzymes exhibited normal levels of a c t iv i ty  
u n til  a f te r  8 h o f exposure to the toxins. By 12 h there was a dramatic 
increase in a c t iv i ty  fo r  a l l  three hydrolases studied. This represented 
a delay in  the onset o f  lysosomal rupture since earie r results in ­
dicated th a t ,  without p r io r  exposure to PVPO, lysosomal enzyme release  
was apparent 6 h a f te r  administration o f CAR (F ig . 1) and 4 h a f te r  
treatment with MUS (F ig . 2 ) .  These results suggested that PVPO acted 
in vivo to s ta b i l iz e  the lysosomal membranes within macrophages which 
ingested CAR or MUS, but that i t s  e ffects  were temporary and that  
lysosomal rupture did occur, a lb e it  6-8 h la te r  than when the toxins 
were given alone.
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Induction of a pseudo-secondary Ab response to IPS required lysosomal 
d e s ta b il iz a t io n . The temporary a b i l i t y  of PVPO to s ta b il iz e  lysosomal 
membranes against the destab iliz ing  effects  of CAR and MUS provided an 
excellent experimental s ituation  fo r an investigation of the mechanism 
underlying the development o f the pseudo-secondary response. By trans­
ferring serum during periods of both lysosomal s ta b il iza t io n  and 
d es ta b il iza t io n , i t  was possible to determine i f  lysosomal damage was 
s p e c if ic a lly  required fo r serum from tox in -treated  mice to prime 
recipients to IPS. The procedure used in these investigations was as 
follows. In every case, donor mice received PVPO 1 h p rior to a second 
treatment, which consisted of an in jec tion  of CAR, MUS, or PBS. Donor 
serum was then harvested fo r transfer to recipients a t 6, 12, and 16 h 
a f te r  the second treatment. Recipient mice were challenged with IPS on 
day 15 and th e ir  sera t i te re d  4 d la te r  fo r  anti-LPS antibody. Table 3 
deta ils  the resu lts . Mice given serum from donors 6 h post-administration  
o f toxin (Groups A and D), which represented a period o f lysosomal s tab i­
l iz a t io n  in PVPO-treated mice (see Figs. 4 and 5 ) ,  were not primed to IPS 
and were unable to mount a pseudo-secondary response when challenged with  
IPS a t  day 15. In contrast, mice which received serum from donors a t a 
time corresponding to lysosomal damage and rupture (Groups B,C,E, and F) 
were primed and did exh ib it a pseudo-secondary response to IPS that was 
sim ilar in magnitude to a true secondary response (Group J ) .  Recipients o f  
serum harvested from donors given PVPO plus a placebo in jec tion  of PBS 
(Group 6 -1 ) showed a typical primary response to a single in jec tion  o f  
IPS a t day 15. These controls served to demonstrate that PVPO was not
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Fig. 4. Treatment with PVPO caused temporary s ta b i l iz a t io n  
of lysosomal membranes in mice exposed to CAR. Mice were 
injected with 4 mg PVPO, i . v . ,  1 h p rio r to the adminstration  
of CAR(5 mg, i . p . )  or an equivalent volume o f PBS. Enzyme analyses
of plasma pooled from three mice were performed a t  the times
indicated a f te r  treatment with CAR. For each enzyme studied, 
the level of a c t iv i ty  present in mice given PVPO + CAR was
expressed as x(enzyme a c t iv i ty  in mice given PVPO + PBS).
Each value shown represents the mean of two experiments.
Symbols:
Line A: Acid phosphatase 
Line 8: ^-D-galactosidase  
Line C: ^-D-glucuronidase
Î :  Indicates the time of in jec tion  o f CAR
40







iV W liO N  X
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Fig. 5. Treatment with PVPO caused temporary s ta b i l iz a t io n  
of lysosomal membranes in mice given MUS. Mice were injected  
with 4 mg PVPO, i . v . ,  1 h prior to the administration of MUS(8 
mg, i . v . )  or an equivalent volume o f PBS. Enzyme analyses of  
plasma pooled from three mice were performed at the times indicated  
a fte r  treatment with MUS. For each enzyme studied, the level 
of a c t iv i ty  present in mice exposed to PVPO + MUS was ex­
pressed as x(enzyme a c t iv i ty  in mice given PVPO + PBS). Each 
value shown represents the mean of two experiments.
Symbols:
Line: Acid phosphatase 
Line B: ^-D-galactosidase  
Line C: d-D-glucuronidase
T: Indicates the time of in jec tion  o f MUS
42
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Day 0 Day 15 Day 19
Donor Recipient
Experimental
Group 1 2 3 mean
A PVPO + CAR d.s. 6 h post CAR LPS 5.0 5.0 5.0 5.0
B PVPO + CAR d.s. 12 h post CAR LPS 8.0 7.0 8.0 7.7
C PVPO + CAR d.s. 16 h post CAR LPS 8.0 8.0 8.0 8.0
D PVPO + MUS d.s. 6 h post MUS LPS 5.0 4.0 4.0 4.3
E PVPO + MUS d.s. 12 h post MUS LPS 8.5 8.0 8.0 8.2
F PVPO + MUS d.s. 16 h post MUS LPS 8.0 8.0 8.0 8.0
G PVPO + PBS d.s. 6 h post PBS LPS 4.0 5.0 5.0 4.7
H PVPO + PBS d.s. 12 h post PBS LPS 4.0 5.0 4.0 4.3
I PVPO + PBS d.s. 16 h post PBS LPS 4.0 5.0 5.0 4.7
J - LPS LPS 8.0 8.0 - 8.0
:
derived from the equation, x=log%(HD/2), where HD represents the reciprocal of the highest dilution 
of sera that produced hemagglutination. Each experimental group value represents the titer of sera 
pooled from four or five mice.
b. 4 mg poly(-2-vinylpyridine-N-oxide) (PVPO) were injected i.v. 1 h prior to either CAR(5 mg, i.p.), 
MUS(8 mg, i.v.), or PBS. Recipient mice received 0.30-0.35 ml donor serum(d.s.), i.p.
c. 10 ug LPS from E. coli 0113, i.p.
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in i t s e l f  responsible fo r inducing the pseudo-secondary response observed 
in other groups. From the above resu lts , i t  was evident that serum 
transferred from CAR or MUS-treated mice was unable to prime the 
recipients to LPS unless lysosomal destab ilization  had occurred in the 
donors and that rupture or damage to lysosomes was a v i ta l  step in the 
generation of a pseudo-secondary response to LPS.
Genetic requirement o f rec ip ient mice for the generation of a pseudo­
secondary Ab response by passive transfer of serum. Previous data 
showed that C3H/HeJ mice were unable to generate a pseudo-secondary 
antibody response when treated with toxins for macrophages (7 6 ) ,  or 
with various fractions o f macrophages (66 ), and la te r  challenged with  
LPS. I t  was postulated that the mice were primed by the treatments 
mentioned, but, because C3H/HeJ mice lacked the genetic a b i l i t y  to 
respond to the Lipid A portion o f LPS (40, 59, 81 ), there was no 
recognition o f the signal required to tr igger a secondary response.
Nude mice were also shown to be incapable o f mounting a pseudo­
secondary response to LPS (76 ). The suggestion here was that nude 
mice, as responders to LPS, were not primed following treatment with  
the macrophage toxins because the priming event was T cell-dependent.
As a coro lla ry  to these studies, an attempt was made to prime C3H/HeJ 
as well as nude mice to LPS by transfer of serum from CAR-treated mice.
As seen in Table 4 , serum from CAR-stimulated RML donors exerted an














Genetic requirement of recipient mice for the generation of a pseudo-secondary Ab response by




















Donor : Recipient Day 0 Day 15 Day 19
Experimental
RML Swiss : C3H/H6J Donor Recipient 1 Group 1 2 3 mean
A CAR d.s. 6 h post CAR LPS 5.0 4.0 4.0 4.3
B PBS d.s. 6 h post PBS LPS 0.0 0.0 0.0
RML Swiss : Nude
C CAR d.s. 6 h post CAR LPS 4.0 3.0 3.0 3.7
D PBS d.s. 6 h post PBS LPS 3.0 2.0 2.5
RML Swiss : RML Swiss
E CAR d.s. 6 h post CAR LPS 8.0 8.0 8.0
P PBS d.s. 6 h post PBS LPS 4.0 4.0 - 4.0
b.
c.
Xf derived from the equation 
of sera that produced hemagglutination 
sera pooled from three or four mice.
5 mg CAR, i.p.; 0.30-0.35 ml donor serum(d.s.), i.p 
10 ug LPS from E. coli 0113, i.p.
x=logt(HD/2), where HD was the reciprocal of the highest dilution 
Each experimental grôup value represents the titer of
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e ffe c t  on the a b i l i t y  of C3H/HeJ mice to respond to a subsequent 
challenge with LPS. C3H/HeJ mice which received normal RML mouse 
serum at day 0 produced no detectable antibody response (Group B) when 
challenged at day 15 with LPS, while those which received serum frcwn 
toxin-treated  mice were found to have a mean t i t e r  of 4.3 (Group A). 
However, because this t i t e r  was much lower than that observed fo r the 
pseudo-secondary response produced in RML recipients (Group E), i t  
probably represented an enhanced primary response made possible a f te r  
priming of C3H/HeJ mice to some component of the LPS molecule had 
already taken place. Such results were consistent with e a r l ie r  reports 
that C3H/HeJ mice were unable to mount a pseudo-secondary response to 
LPS. Previous work which demonstrated that nude mice were unable to  
generate a pseudo-secondary response was also confirmed. Nude mice 
which received serum from CAR-stimulated donors (Group C) were evidently  
not primed by such treatment and responded to a la te r  challenge with  
LPS by producing a typical primary anti-LPS antibody response (as 
compared to control nude mice in  Group D which were given a single in ­
jec tio n  o f LPS 15 d a f te r  a placebo in jec tion  of normal mouse serum).
Genetic requirement o f  donor mice fo r  priming to a pseudo-secondary Ab 
response by passive transfer of serum. In view of the evidence presented 
by other investigators concerning the in a b i l i t y  o f C3H/HeO and nude mice 
to generate a pseudo-secondary response to LPS, i t  was of in te re s t to 
explore whether these stra ins o f mice could act as donors, rather than
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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rec ip ien ts , in generating a pseudo-secondary response by passive 
transfer of th e ir  sera following treatment with CAR. Table 5 shows 
that serum from CAR-stimulated C3H/HeJ mice was able to prime Swiss- 
Webster recipients for a pseudo-secondary antibody response (Group A) 
that was nearly equal q u a n tita t ive ly  to that observed fo ra  true 
secondary response (Group E). Normal C3H/HeJ serum did not have a 
s ig n if ic a n t e ffe c t  on the anti-LPS antibody t i t e r  obtained in Swiss- 
Webster mice (Group B vs. Group F). Nude mouse serum, however, ex­
hib ited the capacity to prime recip ients fo r  an anti-LPS response 
that resembled a true secondary response in magnitude, whether or not 
the donors had been treated with CAR (Groups C and D).
Serum transferred from mice treated with CAR or MUS did not contain 
residual toxic partic les  capable of inducing destab ilization  of 
lysosomal membranes in rec ip ient mice. Electron microscopy studies 
have demonstrated a s im ila r ity  in structure between ex trace llu la r  
and in t ra c e l lu la r  CAR (1 9 ) ,  suggesting th at th is material was not 
read ily  digested and that i t  was extruded from impaired macrophages 
in a nearly or completely in ta c t form. Furthermore, studies with 
microparticulate s i l ic a  (MUS) have shown th a t ,  once released from 
k i l le d  macrophages, i t  was as cytotoxic as the orig inal preparation (3 ) .  
Clearly  then, the p o s s ib i l i ty  existed that the serum transferred from 
mice treated with CAR or MUS contained residual or recycled toxin and 
that the pseudo-secondary response to LPS generated from such transfers  
was the resu lt  o f  the e ffec ts  o f the toxins themselves, rather than the
















Genetic requirement of donor for priming for a pseudo-secondary Ab response by passive transfer of




















Donor : Recipient Day 0 Day 15 Day 19
Experimental
C3H/H6J : Swiss-Webster Donor Recipient Group i 2 3 mean
A CAR d.s. 6 h post CAR LPS 7.0 7.0 8.0 7.3
B PBS d.s. 6 h post PBS LPS 5.0 5.0 - 5.0
Nude : Swiss-Webster
C CAR d.s. 6 h post CAR LPS 7.0 8.0 8.0 7.7
D PBS d.s. € h post PBS LPS 8.0 8.0 8.0
None : Swiss-Webster
E - LPS LPS 8.0 8.0 8.0




derived from the equation, x-logt(HD/2), where HD was the reciprocal of the highest dilution of sera 
that produced hemagglutination. Each experimental group value represents the titer of sera pooled 
from three or four mice.
5 mg CAR, i.p.; 10 ug LPS from E. coli 0113, i.p.; 0.30 ml donor serum(d.s.), i.p.
c. 10 ug LPS from E. coli 0113, i.p.
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demonstration o f some unique factor found in the serum of mice exposed 
to the toxins. To determine i f  residual or recycled toxin was present 
in  the serum transferred , the level of AcPh, g-Gal, and ^-GlcU a c t iv i ty  
was assessed in plasma from recip ient mice. I t  was assumed th at i f  
the toxins were present, damage to macrophages (or more s p e c if ic a l ly  
lysosomes) would have occurred w ith in  recip ient mice and the a c t iv i ty  
of the lysosomal marker enzymes would have risen above normal leve ls .  
Groups of three mice each received an in jec tion  of e ith e r  normal mouse 
serum (NMS) or serum derived from mice treated previously with CAR or 
MUS. At 6, 12, and 24 h post-transfer o f the serum, rec ip ient mice 
were bled and the plasma recovered from each group pooled fo r enzyme 
analyses. Mice which received serum from toxin-treated  mice exhibited  
normal levels o f acid hydrolase a c t iv i t ie s  as compared to mice which re­
ceived NMS, a t  a l l  the times examined (spec ific  data not shown). There­
fore , i t  was concluded that the serum transferred from mice treated  
with CAR or MUS did not contain residual toxic partic les capable of  
exerting damage to lysosomes in rec ip ien t mice.
SI
Effect o f CAR on the tissue d is tr ib u tio n  of Cr-labeled LPS in mice. 
Considerable controversy has surrounded the question of whether 
endotoxins were able to escape from the gut. Some investigators have 
shown absorption o f endotoxin from normal in testine  (52, 73) and from 
surg ically  implanted i le a l  segments (3 4 ) ,  while others have claimed 
that no such absorption occurred (12, 83 ). In re la tio n  to the present
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study, the question of absorption of endotoxin became important in 
that such LPS might be taken up by macrophages and stored within the 
lysosomes. ( I t  has been suggested that lysosomes served as the in t r a ­
c e l lu la r  targets fo r endotoxin on the basis that endotoxins induced 
lysosomal in s ta b i l i ty  and caused the release o f lysosomal enzymes 
into tissues) (13, 16, 32, 57, 82, 91 , 92). Consequently, i t  may have 
been th a t ,  upon CAR or MUS-induced lysosomal rupture, LPS i t s e l f  rather  
than an LPS-like molecule, was released and was responsible for priming 
mice for what has been called a pseudo-secondary response. Under 
these conditions, however, the response observed a f te r  challenge with  
LPS would have been a true secondary response.
Although no e ffo rts  were made to investigate further the issue 
concerning escape of endotoxin from the gut, an experiment was designed 
to tes t the proposal that treatment with CAR could have caused the
release of LPS from tissue where i t  was presumably bound within the
51lysosomes of macrophages. The same dose o f Cr-labeled LPS was 
administered, i . v . ,  to a l l  mice in the study and 24 h was allowed for  
the LPS to be cleared from the peripheral blood supply by the r e t i ­
culoendothelial system (RES), p r im arily  Kupffer c e l ls ,  and stored w ith in  
the lysosomes. Then, e ith e r  CAR or PBS was in jected , i . p . ,  and 6 h 
la te r ,  a t  the time corresponding to the rupture o f lysosomes s p e c if ic a l ly
within macrophages, the mice were exsanguinated and the various tissues
51assayed fo r the presence of Cr-labeled LPS. The results are shown 
in  Table 6. Following treatment with CAR, there was a s ig n if ica n t
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L iv e r 29000 + 1250 58.0 + 2.5
Spleen 265 + 60 0.5 + 0.1
d.
Blood 476 + 143 0.9 + 0.3
e.














L iv e r 25000 + 1040 49.9 + 2.1 .001
Spleen 257 + 67 0.5 + 0.1 .2
d.
Blood 836 + 134 1.7 + 0.3 .05
e.
Serum 961 + 153 1.9 + 0.3 .01
f.
PF 245 + 141 0 .5 + 0.3 .001
Carcass 27400 + 2370 54.7 + 4.7 .001
a. Ail mice received 50,000 ng Cr-labeled LPS i.v. at -24h. At time 0, 5 mg CAR or an equivalent volume 
of PBS was injected, i.p. At 6h, mice were exsanguinated ard the various organs extracted for assay.
b. Nanograms LPS were calculated by the following formula; ng LPS = (50,000 ng LPS)x(counts/organ) / 
(counts/50,000 ng LPS). All sanples were counted for 1 min and were corrected for background and de­
cay. Each value represents the mean of six mice/group + the standard deviation about the mean, 
p values were calculated by the Student’s t-test
1.0 ml blood was counted. The amount of LPS was determined by assuming a circulating blood volume of 
1.5 ml.
0.2 ml serum was counted. Calculations were made assuming 0.7 ml recoverable serum from 1.5 ml blood.
c.
d.
e.f. 1.0 ml peritoneal fluid (PF) was ©ctracted and counted. No further adjustments were made.
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decrease (p < 0 .0 0 1 ,  as compared to normal) in the amount of ^^Cr-LPS 
found In the l iv e r .  At the same time, there was a corresponding
Cl
increase in the amount o f Cr-LPS detected in blood (p c O .0 5 ) ,  serum 
(p < 0 .0 1 ) ,  peritoneal f lu id  (pcO .O O l), and the carcass ( p < 0.001).
No s ig n if ic a n t change (p > 0 .2 )  in the percent o f ^^Cr-LPS located in 
the spleen was detected a f te r  administration o f CAR. These results  
seemed to indicate th a t ,  i f  present, LPS could have been liberated from 
lysosomes (following rupture of the lysosomal membrane by CAR) and 
redis tributed  to other tissues where i t  would have been able to sensitize  
LPS-responsive B c e lls  fo r  a secondary response.
Demonstration of E. co li as part of the normal gut f lo ra  o f resident mice. 
Although Escherichia c o l i , a lactose fermenting. Gram negative rod, 
has been id e n t if ie d  as part o f the normal in te s tin a l f lo ra  o f many 
animal species, previous work (66) indicated that E.  co li was absent 
from the in te s tin a l t ra c t  o f Swiss-Webster derived RML mice. Because 
the presence of indigenous LPS, orig inating  from E.  co li in the gut, 
could have affected the immune response to exogenously administered 
LPS, another attempt was made to iso la te  and id e n t i fy  the Gram negative, 
lactose positive  in te s t in a l f lo ra  o f RML mice. Both male and female 
mice were used in  the study and samples from nine mice were cultured.
The en tire  in te s t in a l contents from individual mice were suspended in  
2 ml s te r i le  PBS and streaked onto EMB and McConkey's agar. A fte r  
18-24 h incubation,six well iso lated , lactose positive  colonies were
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chosen from e ith e r  p late and restreaked on a blood agar medium. An 
e f fo r t  was made in choosing colonies to pick those colony types which 
were morphologically d is t in c t  from one another. Since several of the 
isolates were morphologically id e n tic a l,  only 2-3 of the colonies (per 
mouse cultured) which were chosen fo r re iso la tion  were fu rther id e n t i ­
fied  by standard biochemical tests (IMVIC series, TSI and SIM media, 
decarboxylase reactions). A ll mice were shown to carry £ .  co li as 
part of th e ir  normal gut f lo ra .  Details concerning the number of 
isolates p o s it iv e ly  id e n tif ie d  as Ê. co li vs. the number tested are 
shown in Table 7. The only other lactose fermenting. Gram negative 
rod id e n t if ie d  was found to belong to the genus K leb s ie lla . Non­
lactose fermenting. Gram negative rods were also isolated from a few 
mice, but no fu rther characterizations were made o f these organisms.
A fte r  determining that E. coli was indeed a normal inhabitant o f the 
gut of RML mice, i t  was necessary to investigate whether any o f the 
Gram negative organisms isolated would cross-react immunologically with  
£ .  co li 0113, the p a rt ic u la r  antigenic varie ty  used in the study of the 
pseudo-secondary response. Nearly a l l  the colonies which were 
transferred to blood agar medium were tested fo r  c ro s s-rea c tiv ity  with  
£ . coli 0113 and 0111 by the co-agglutination te s t .  Antibody specific  
for the 0113 or 0111 determinant was adsorbed to formal in i zed 
Staphylococcus aureus and one drop of the sensitized aureus was 
added to an equal volume of a heavy bacteria l suspension. Care was 
taken to boil the bacteria l samples fo r 20-30 min p rio r to testing  in







































Identified /# a. 




cross-reactive with /# b. 
0113 E. coli 0111 /  Tested
A 4 2/2 0/4 0/4
B 4 2/2 2/4 2/4
C 6 2/2 0/6 0/6
D 6 2/3 0/6 0/6
E 6 2/2 0/6 0/6
F 6 1/3 0/6 0/6
G 6 2/3 0/6 0/6
H 6 2/2 0/6 0/6
I 6 2/2 0/6 0/6
in
VI
McConkey's agar for isolation of Gram negative, lactose positive colonies.
a. The biochemical tests used in the identification of lactose positive colonies 
included: IMVIC series, motility, urease production, decarboxylase and TSI 
reactions.
b. Isolates were determined to be cross-reactive with E. coli 0113 and 0111 by 
the co-agglutination test.
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order to unmask any 0-sornatic antigens which may have been present.
Only two of the f i f t y  isolates examined proved to be cross-reactive  
with coli 0113 (Table 7 ) .  These same two isolates also showed 
cross-reactiv ity  with co li 0111 and were id en tif ied  as coli 
themselves. Since these samples were derived from the same mouse, 
and cultures from eight other mice showed no such c ross-reac tiv ity ,  
i t  was concluded that resident RML mice, while they did harbor Ê. coli 
as part o f th e ir  normal gut f lo r a ,  did not possess an IE. coli 
population which exhibited c ro s s-rea c tiv ity  with e ith er the 0113 or 0111 
antigenic determinants o f co li .
E ffect o f CAR on the polyclonal ac tiva tion  of mouse spleen c e l ls . In 
the work of Kolb, e t (51, 72 ), CAR has been described as a B-cell
mitogen fo r the mouse system. While the induction of ce ll p ro li fe ra ­
tion  has not been found to corre la te  d ire c t ly  with the a b i l i t y  to 
stimulate Ig synthesis (48, 6 1 ) ,most B c e l l  mitogens have also been 
shown to function as polyclonal activators of Ig synthesis (23, 62).
I t  was of in te rest to determine i f  CAR induced nonspecific stimulation  
of Ab production because the presence of polyclonal Ab in the serum 
used to prime mice fo r  a pseudo-secondary response could have po­
te n t ia l ly  influenced the sp ec if ic  response obtained to a subsequently 
administered Ag (33, 53). Three groups of six mice each were treated  
with CAR and th e ir  spleens were excised fo r  analysis 6 h, 2 d, and 5 d 
la te r .  Each spleen was assayed in d iv id u a lly  and the number o f d ire c t
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plaque-forming c e lls  (PFC)/ spleen spec ific  for SRBC, rat RBC (RRBC), 
and LPS from £ .  co li 0113 and 0111 was quantified by a hemolytic 
plaque assay. Groups of untreated mice and mice given LPS (a known 
polyclonal ce ll  ac tiva tor) were included as controls. As indicated 
in Table 8 , polyclonal activation of mouse spleen ce lls  by CAR was 
apparent 2 d a f te r  treatment (Group D ). The number of PFC detected 
at this time was well above background (Group A) fo r  a l l  four Ags 
tested and was equal, or nearly equal, in  magnitude to the number of 
PFC observed following stimulation with LPS (Group B). Spleen ce lls  
taken from mice 6 h (Group C) and 5 d (Group E) a f te r  treatment with 
CAR showed background numbers of PFC.

















































Anti-0113 Anti-0111 Anti-SRBC Anti-RRBC
A NONE 12 ± 5 15 ± 10 75 ± 23 48 ± 17
B LPS 2 d 10,750 ± 848 8,675 ± 601 3,825 i 248 3,350 ± 141
C CAR 6 h 68 ± 11 42 ± 3 128 ± 11 55 ± 9
D CAR 2 d 5,458 ± 529 4,575 ± 417 3,300 ± 482 2,900 ± 278
E CAR 5 d 81 ± 38 77 ± 21 68 ± 18 78 ± 25
rat RBC (RRBC) and LPS from E. coli 0113 and 0111 was determined by a hemolytic plaque 
assay. The CAR values represent the mean of six mice/group. The untreated and LPS 
values represent the mean of two groups of two mice each in which the spleens were 
pooled.




From the data presented, i t  was evident that a fac to r , which was 
able to sensitize  mice fo r a pseudo-secondary antibody response to 
LPS, was released to the serum following destab iliza tion  of lysosomal 
membranes w ith in  macrophages. The release of this factor was inhibited  
by administering a lysosomal s ta b il iz in g  agent, PVPO, p rior to t re a t ­
ment with CAR or MUS. Furthermore, i t  was unlike ly  th at the pseudo­
secondary response was induced by LPS i t s e l f  because there did not
appear to be a su itab le  source o f endogenous LPS.
Generation o f  a pseudo-secondary response by passive transfer of 
serum from CAR and MUS-treated mice. Previous investigators have 
proposed th at priming fo r a pseudo-secondary response to LPS was 
caused by a fac to r  liberated  from lysed macrophages, or more s p e c if i ­
c a l ly  from ruptured lysosomes (66, 76). However, i t  was not u n ti l  the
curreot study th at the presence of such a factor in the mouse system 
was demonstrated in  vivo . In th is  report i t  was shown that serum, 
harvested from donors treated with MUS or CAR, was able to sensitize  
recip ient mice to LPS. In p a rt ic u la r ,  mice were primed fo r a pseudo­
secondary response by serum which was collected from donors 6, 12, and 
16 h a fte r  exposure to MUS and 6 and 48 h a f te r  treatment with CAR.
A preliminary analysis o f the kinetics and s p e c if ic ity  o f lysosomal 
enzyme release had revealed that damage to lysosomes within macrophages
59
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occurred 6 h a f te r  the introduction of e ith e r  CAR or MUS. Thus, i t  
was possible to correlate  the discharge of lysosomal products from 
macrophages at 6 h with the a b i l i t y  of serum harvested at that time 
to prime mice fo r  a pseudo-secondary response. An attempt to establish  
any fu rther temporal relationships between elevated lysosomal enzyme 
a c t iv i t ie s  and the a b i l i t y  of serum to sensitize recipients to LPS 
proved to be o f l i t t l e  value. Serum obtained during a second phase 
of lysosomal damage induced by CAR (12-16 h) was unable to prime mice 
for a pseudo-secondary response, while serum collected during the 
ensuing period o f lysosomal s ta b i l i t y  (48 h) was able to sensitize  
mice to LPS. In add ition , serum from donors exposed to MUS fo r 12 as 
well as 16 h was capable o f inducing a pseudo-secondary response to  
LPS, yet the levels  o f  hydrolase a c t iv i t ie s  detected at these times 
varied from nearly normal (12 h) to greatly  elevated (16 h). Con­
sequently, although i t  appeared that the in i t i a l  rupture of macrophage- 
derived lysosomes lead to the release o f a lysosomal component which 
was able to prime mice to LPS, i t  was apparent that the subsequent 
immunological a c t iv i t y  of th is component in serum was not re lated to  
the attendant levels o f lysosomal hydrolase a c t iv i t ie s .
Several factors may have influenced the immune expression of th is  
LPS-like substance and explained why, a f te r  the f i r s t  6 h of exposure 
to the toxins, such an inconsistent pattern was observed between the 
periods of lysosomal in s ta b i l i t y  and the times a t which serum from 
CAR- and MUS-treated mice was able to prime recipients fo r a pseudo­
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secondary response. Although a number of researchers (97, 71) have 
reported th a t ,  in general, macrophages which in te r io r ize d  large numbers 
of partic les  were rendered less active in phagocytosis, i t  has been 
suggested (10, 14) that a small population of macrophages which survived 
the toxic e ffects  of CAR-ingestion were activated and exhibited en­
hanced, ra ther than diminished, phagocytic properties. I f  CAR- 
treatment resulted in the activation  o f some surviving macrophages, 
i t  was possible that these ce lls  could have rapid ly cleared the priming 
factor from the serum in spite of overt RES impairment, thereby 
accounting fo r the in a b i l i t y  of serum harvested a t  12 and 16 h to prime 
mice fo r a pseudo-secondary response. Activation o f macrophages has 
not been reported following the administration o f MUS, and in fa c t ,  
one investigator has claimed that uptake o f MUS always in i t ia te d  ce ll  
death (25 ). Therefore, the prolonged (up to 12 and 16 h) immunological 
a c t iv i ty  of the priming factor in serum derived from MUS-treated mice 
may have been a ttr ib u tab le  to the overall depressed state  of the RES 
and the in a b i l i ty  of a phagocytic ce ll  population to sequester the Ag.
There remained one other plausible explanation fo r  why serum 
obtained 16 h following treatment with MUS was able to prime mice fo r  
a pseudo-secondary response. Since th is period o f time corresponded 
to a second rise  in lysosomal hydrolase a c t iv i ty ,  i t  may have been 
that recycled toxin or general tissue damage lead to fu rther lysosomal 
la b i l iz a t io n  which was, in turn , followed by the re-emission of the 
component responsible fo r sensitiz ing  mice to LPS. CAR-stimulated
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mice also exhibited a second peak in lysosomal enzyme a c t iv i ty  (16 h),  
yet serum taken from donors at th is time did not prime recipients for  
a pseudo-secondary response. One reason fo r th is  may have been that the 
priming fac tor was not released for a second time in mice exposed to 
CAR. The increase in  hydrolase a c t iv i ty  detected at 16 hcould have 
been a consequence of e ith e r  secondary tissue damage or the recycling 
of CAR in smaller doses to newly matured macrophages. Both of these 
events could have resulted in the secretion o f hydrolytic enzymes from 
lysosomes without rupture o f the vesicles or discharge of the priming 
fac tor i f  i t  was bound to the membrane. I f  the form in which the 
priming fac tor was liberated in vivo played a role in i t s  immunolo­
gical a c t iv i ty ,  then perhaps this LPS-like molecule was present in the 
serum a f te r  the second period of CAR-induced lysosomal damage, but,  
because of the abnormal functional state of the RES and the overall 
systemic damage that was apparent at 16 h, i t  may not have been con­
verted into  a form in which the LPS-like immunodeterminant(s) was 
exposed to and recognized by the immune system o f rec ip ien t mice. This 
may then have accounted fo r the a b i l i t y  o f serum collected 48 h a f te r  
the administration o f CAR to prime recip ients to LPS. By 48 h, RES 
function in CAR-stimulated mice would have ju s t  begun to improve (11) 
and recovering or newly matured macrophages may have been able to process 
the priming fac to r into the proper immunogenic form. I t  was apparent, 
though, that once RES a c t iv i ty  had returned to normal levels (5 d 
a f te r  treatment with e ith er CAR or MUS) serum from toxin -treated  mice
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no longer contained a component which was able to prime recip ient mice 
fo r  a pseudo-secondary response.
F in a l ly ,  in a related experiment, i t  was shown that serum from 
mice given CAR or MUS did not contain residual toxic partic les capable 
of causing lysosomal in s ta b i l i ty  in rec ip ient mice. Therefore, the 
mechanism of priming fo r a pseudo-secondary response by various sera 
was not effected or affected by contamination with CAR or MUS.
When viewed in to te , the above information indicated that lysosomal 
d es ta b il iza t io n , induced by CAR or MUS, lead to the appearance in serum 
of a substance which was an tigen ica lly  s im ila r  to IPS and, thus, 
capable o f sensitiz ing  mice for a pseudo-secondary response to IPS.
In addition, the immunological a c t iv i ty  o f th is  substance in serum was 
p o te n tia lly  influenced by a varie ty  of conditions which undoubtedly 
varied with respect to the macrophage toxin that was i n i t i a l l y  in jected.
Induction o f a pseudo-secondary Ab response to IPS required 
lysosomal d e s ta b il iz a t io n . Two additional experiments were performed 
in order to corroborate or disprove the theory that the mechanism by 
which serum gained the capacity to prime recip ients fo r  a pseudo­
secondary response to IPS involved lysosomal d es tab iliza tion . In one 
experiment i t  was shown that serum from mice in jected with TT, a 
macrophage in h ib ito r  which has not been demonstrated to a l te r  lysosomal 
s ta b i l i t y ,  was unable to sensitize  mice to IPS. In a subsequent in ­
vestigation , PVPO was employed to protect lysosomes from the la b i l iz in g  
effects of CAR and MUS. Since the protection afforded by PVPO-treatment
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proved to be temporary, i t  was possible to obtain serum from donor 
mice during periods of both lysosomal s ta b i l i ty  and in s ta b i l i ty .
Mice which received serum harvested before lysosomal damage occurred 
did not ex h ib it  a pseudo-secondary antibody response when la te r  
challenged with LPS. On the other hand, a pseudo-secondary response 
was observed in mice which had received serum collected while lysosomal 
rupture was taking place. From these resu lts , i t  was evident that  
lysosomal d e s ta b il iza t io n  was necessary for serum to acquire the 
a b i l i t y  to immunize mice fo r  a pseudo-secondary response.
Genetic requirements fo r the generation of a pseudo-secondary response. 
An investigation was made into the genetic requirements o f the donor 
and rec ip ien t mice used in the study of the generation of a pseudo­
secondary antibody response by passive transfer of serum. I t  was 
found that nude mice which received serum from CAR-stimulated, RML
mice (serum from the RML s tra in  had already been shown to contain the
priming factor) were not primed by such treatment and produced a 
typical primary antibody response when challenged with LPS 15 d la te r .  
The fa i lu re  of nude mice to respond in a pseudo-secondary fashion 
was interpreted to mean that the priming event was I  cell-dependent. 
These results were supported by the data of a previous study (76) in
which a single in jec tio n  o f LPS was unable to e l i c i t  a pseudo­
secondary response in nude mice that had been treated d ire c t ly  with  
CAR or MUS 21 d e a r l ie r .  Likewise, when i n i t i a l l y  exposed to toxins 
for macrophages (76) or various fractions of macrophages (6 6 ) ,
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C3H/H&J mice have also been shown to be incapable of mounting a 
pseudo-secondary response to LPS. I t  was suggested that priming of 
the mice took place, but th a t ,  because C3H/HeJ mice were genetica lly  
unresponsive to the Lipid A portion of LPS, there was no recognition  
of the signal necessary to tr ig g e r a secondary response when these 
mice were subsequently challenged with LPS. The work presented herein 
has substantiated these claims. The anti-LPS antibody t i t e r  that was 
observed in  C3H/HeJ mice, which were injected with serum from CAR- 
treated donors and la te r  immunized with LPS, was s ig n if ic a n tly  higher 
than that obtained in C3H/HeJ mice o r ig in a l ly  given normal mouse serum, 
but the response was not considered to be a pseudo-secondary response 
because i t  did not reach the same order o f  magnitude as the pseudo­
secondary response manifested by RML mice which were given identical 
treatment. In order fo r C3H/HeJ mice to have exhibited a secondary- 
type response to any of the immunodeterminants o f LPS, the mechanism 
for the activation  o f the appropriate ce lls  would have had to have 
been independent o f the recognition of the second signal provided by 
Lipid A. I f  an a lte rn a te  pathway fo r 8̂  ̂ ce ll  activation  was involved 
in the mechanism fo r  the generation of a pseudo-secondary response, 
then the anti-LPS antibody t i t e r  obtained in C3H/HeJ mice would have 
been expected to be s im ila r  q u a n tita t iv e ly  to that obtained in RML mice. 
Since the level of antibody production was much lower in C3H/HeJ mice, 
i t  seemed l ik e ly  that the response observed in these mice was merely 
a representation o f an enhanced primary antibody response.
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Although C3H/HeJ mice were unable to serve as recipients for the 
generation of a pseudo-secondary response by passive transfer of serum, 
i t  was shown th a t ,  following the administration of CAR, serum harvested 
from these mice was able to sensitize  Swiss-Webster mice for a pseudo­
secondary response. Nude mouse serum, however, proved to be e ffec tive  
in priming recipients to LPS whether or not the donors had been treated  
with CAR. This was an interesting observation in view o f the proposal 
(20, 65) that nude mice have compensated fo r the lack of thymus- 
derived immune functions by developing a more highly activated RES. 
Because activated macrophages have been found to secrete high levels  
of lysosomal enzymes (as compared to resting macrophages) (68 ), i t  
was possible that a lysosomal product, capable o f  sensitiz ing mice for  
a pseudo-secondary response, was present as a normal constituent of 
nude mouse serum. With the demonstration that serum from a varie ty  of 
d if fe re n t  strains of mice treated with CAR (responders as well as non­
responders to LPS) was capable o f priming recipients to LPS, i t  was 
conceivable that the factor which was responsible fo r the priming event 
was a lysosomal component present in  a l l  mice.
Endogenous LPS and the pseudo-secondary response. Several investigators  
have suggested that bacteria l endotoxins were able to escape from the 
gut (34, 52, 73). When th is p o s s ib i l i ty  was viewed in conjunction with 
the finding that LPS was stored undegraded w ith in  the lysosomes of 
macrophages (13 ), i t  became important to determine i f  la b i l iz a t io n  of 
lysosomal membranes by macrophage toxins could have liberated LPS
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i t s e l f ,  rather than a molecule which was an tigen ica lly  sim ilar to LPS, 
from damaged c e lls .
In one approach to the study of th is problem, a standard dose of
51 Cr-labeled LPS was administered to several mice and 24 h was allowed 
fo r  the LPS to accumulate within the lysosomes o f ac tive ly  phagocytizing 
macrophages. Then, CAR was injected and 6 h la te r ,  a t the time 
corresponding to the rupture of lysosomes s p e c if ic a lly  within macro­
phages, various tissues were removed from the mice and assayed fo r the 
51presence o f Cr-LPS. The results o f th is  experiment showed that i f  
LPS were present within lysosomes, then i t  could have been released 
to the serum (as well as other tissues) following destab ilization  of  
lysosomal membranes. Considering that very small doses (10”  ̂ to 10’ ^̂  
jug) of LPS have been demonstrated to prime animals fo r a secondary 
response (74, 79 ), i t  was evident th at even i f  a seemingly negligible  
quantity o f LPS was released from lysosomes iji s i tu , that amount o f  
LPS probably would have been s u f f ic ie n t  to prime mice for what has 
been called a pseudo-secondary response. However, the like liness of  
such a priming event depended on whether there was a suitable source of 
endogenous LPS. In an e a r l ie r  report (6 6 ) ,  i t  was proposed that the 
pseudo-secondary response was spec ific  fo r  LPS from JE. coli 0113. 
Therefore, a characterization was made of the Gram negative, lactose 
positive in te s tin a l f lo ra  of resident mice. While a l l  o f the mice 
cultured were found to carry £ .  co li  as part o f th e ir  normal gut f lo r a .
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i t  was demonstrated that these mice did not, in  the great m ajority of 
cases, harbor an co li (or K1ebsiella) population which was cross­
reactive immunologically with coli 0113. Two sources of LPS that 
were not examined fo r cross-reactiv ity  with co li 0113 included the 
Gram negative anaerobic and Gram negative, non-lactose fermenting, 
aerobic f lo r a .  I t  was un like ly  that an anaerobic bacterium would have 
cross-reacted with E.  co li because these groups have not been related  
sero log ica lly . Many of the lactose negative, aerobic genera, on the 
other hand, have exhibited antigenic s im ila r it ie s  to E.  coli 
serotypes (2 9 ) ,  but i t  was doubtful that an LPS molecule derived from 
a lactose negative species could have induced the pseudo-secondary 
response because bacteria o f th is  type were not isolated from every 
mouse cultured. A f in a l  consideration included the p o s s ib i l i ty  that  
an immunologically unrelated LPS serotype was taken up by macrophages, 
processed w ith in  the lysosome, and converted into a form which exhibited  
antigenic s im ila r i t ie s  to LPS from E.  co li 0113. However, the 
generation of a pseudo-secondary response was shown to be I  ce ll  
dependent and, based on th is  as well as the above information, i t  
appeared th at indigenous LPS could not have been responsible for in ­
ducing the pseudo-secondary response.
Polyclonal ac tiva tio n  o f mouse spleen ce lls  by CAR. The in tra c e l lu la r  
pathways culminating in blastogenesis o f B ce lls  and in polyclonal 
Ig synthesis have generally been considered as independent, but closely
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linked events (38, 39, 48, 61) and most B cell mitogens have also been 
id e n t if ie d  as polyclonal B ce ll activators (23, 62). CAR has been 
demonstrated to function as a B ce ll  mitogen in the mouse system 
(51, 72) and, therefore , the p o s s ib il i ty  existed that i t  also 
stimulated polyclonal ac tiva tio n  of murine B c e lls .  The importance 
of nonspecific Ab production by CAR, in re la tion  to the present study, 
was rooted in the work o f For ni, e t  (33) who showed that polyclonal 
IgM Abs directed against SRBC were able to induce, in the absence of  
Ag, an Ab response o f the same s p e c if ic ity  as the injected Abs. Based 
on Forni's report, which other investigators have not supported (41 ),  
i t  was conceivable th a t ,  i f  CAR treatment resulted in the production of 
a heterogenous population o f anti-LPS Abs, these Abs would have been 
present in  the serum transferred to other mice and could have activated  
B cell clones of the same s p e c if ic ity  to synthesize Ab and d if fe re n t ia te  
into memory c e lls -  As a re s u lt ,  the so-called pseudo-secondary response 
obtained a f te r  challenge with LPS would not have been a demonstration of 
some unique factor found in the serum, but rather the e ffects  o f an Ab 
population induced by polyclonal ac tiva tion  with CAR.
As indicated from the data presented in th is study, polyclonal 
activation o f mouse spleen ce lls  by CAR was apparent 2 d a f te r  treatment. 
In view of th is evidence alone, i t  may have been plausible that the 
pseudo-secondary response generated by serum collected 2 d following  
administration of the toxin could have been induced by polyclonal Abs.
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However, serum harvested 6 h a f te r  CAR-treatment was also capable 
of priming recip ients for a pseudo-secondary response to LPS and 
polyclonal ac tiva tion  was not detected in mice exposed to the toxin 
fo r 6 h. Consequently, the orig inal proposal - that priming to LPS 
was caused by a factor present in serum following lysosomal d e s ta b il i ­
zation -  appeared to be the more l ik e ly  explanation for the generation 
of a pseudo-secondary response by serum transfer from CAR-stimulated 
donors.
The a b i l i t y  o f serum from MUS-treated mice to prime recipients to 
LPS also argued against the p o s s ib i l i ty  that the pseudo-secondary 
response was induced by CAR through the action o f polyclonal Abs. To 
date, MUS has only been shown to a ffe c t  B lymphocytes in d ire c tly  (55) 
and therefore, i t  was highly un like ly  that the administration o f MUS 
resulted in nonspecific stimulation o f murine 8 c e lls  and the accumu­
la t io n  o f polyclonal Abs in the serum. Since the body of evidence 
concerning the means by which serum from MUS-treated mice was able to  
sensitize recip ients for a pseudo-secondary response has pointed toward 
the presence of a unique substance released from lab il ize d  lysosomes, 
i t  was doubtful that CAR, which also caused lysosomal des tab iliza tion ,  
would have fa i le d  to l ib e ra te  the same substance.
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V. SUMMARY
The phenomenon of pseudo-secondary responsiveness to a single  
in jection  o f LPS was o r ig in a lly  described by Becker and Rudbach (11).
I t  was noted that mice which had been treated with the macrophage 
toxins, CAR and MUS, produced a secondary-type Ab response when 
challenged with LPS from coli 0113 21 d la te r .  A subsequent in ­
vestigation (76) revealed that the generation of a pseudo-secondary 
response to LPS followed the same k in e tic  and genetic requirements 
as a true secondary response and that priming to LPS seemed to be 
dependent upon lysosomal destab iliza tion  within macrophages. In a 
more recent report (66 ) ,  i t  was shown that murine macrophages contained 
a component, presumably of lysosomal o r ig in ,  which was cross-reactive  
immunologically with LPS from coli 0113. Therefore, the theory 
has evolved that priming fo r  a pseudo-secondary response was caused 
by a molecule(s) released from lysosomes following MUS or CAR-induced 
lysosomal rupture w ith in  macrophages. The in ten t o f the current study 
was to determine i f  the presence of an immunogenic molecule, capable of 
sensitizing mice to LPS, could be detected in vivo a f te r  the adminis­
tra tion  of CAR or MUS. I t  was shown that serum harvested from mice 
given these toxins contained a fac tor which was able to prime re­
cip ient mice fo r a pseudo-secondary response. The appearance of the 
priming factor in  serum was correlated with the onset o f lysosomal
71
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d es tab iliza tion  and could be prevented from occurring by a r t i f i c i a l l y  
s ta b il iz in g  lysosomal membranes with the use of PVPO or by administering 
TT, a macrophage in h ib ito r  which did not a ffe c t  lysosomal s ta b i l i ty .
In addition, i t  was demonstrated that the priming fac tor was liberated  
from the lysosomes o f C3H/HeJ and nude mice, although neither type of 
mouse was able to respond in a pseudo-secondary fashion to a single  
dose of LPS when i n i t i a l l y  injected with serum containing the priming 
factor. F in a l ly ,  i t  appeared that LPS i t s e l f  was not responsible 
for sensitiz ing  mice fo r a pseudo-secondary response because repre­
sentatives o f the mice used in th is study did not possess an endogenous 
bacterial f lo r a  which exhibited immunological c ross-reac tiv ity  with 
E. coli 0113.
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